CA
NZ
UK
AU
IND
US
Microsoft Corp (NASDAQ:MSFT) saw its shares decline roughly 6% in after-hours trading after reporting Q2 FY26 results. This contrasted sharply with Meta Platforms (NASDAQ:META), whose shares rose despite similarly aggressive AI-relatedcapital expenditureprograms.
Starbucks (NASDAQ:SBUX) shares slipped 0.6% on Wednesday after the company released its first-quarter fiscal 2026 earnings report, which showed mixed financial performance. While the coffee chain exceeded analyst expectations onrevenue, weaker profitability limited investor confidence.
Textron (NYSE:TXT) released its fourth-quarter and full-year 2025 financial results on Wednesday, triggering a sharp market reaction. The company’s shares declined by nearly 8% during the trading session following the announcement.
United Parcel Service (NYSE:UPS) reported fourth-quarterrevenueof USD 24.5 billion, slightly ahead of market expectations. Adjustedearningsfor the quarter came in at USD 2.38 per share, exceeding consensus estimates of USD 2.20 per share. For the full year, UPS generated total revenue of USD 88.7 billion, …
Meta Platforms, Inc. (Nasdaq:META) has released its financial results for the quarter and full year ended December 31, 2025.CEO Mark Zuckerberg stated, "We had strong business performance in 2025. I'm looking forward to advancing personal superintelligence for people around the world in 2026."The report …
Meta Platforms, Inc. (Nasdaq:META) has released its financial results for the quarter and full year ended December 31, 2025.CEO Mark Zuckerberg stated, "We had strong business performance in 2025. I'm looking forward to advancing personal superintelligence for people around the world in 2026."The report …
Market Movers:On Tuesday, the top gainers were TEN Holdings, Inc. (+177.17%), followed by Global Interactive Technologies, Inc. (+118.32%). On the contrary, Cardiff Oncology, Inc. (-31.97%), and Commvault Systems, Inc. (-31.10%) declined the most the same day.
CytoDyn Inc. (OTC:CYDY) announced that it has received dedicated funding from an anonymous benefactor to initiate an Expanded Access Program (EAP) for its investigational monoclonal antibody, Leronlimab, in patients with triple-negative breast cancer (TNBC). The funding is earmarked specifically for the establishment and administration …
Belite Bio, Inc (NASDAQ:BLTE), a clinical-stage biotechnology company, announced the completion of patient enrollment in its Phase 2/3 DRAGON II clinical trial for tinlarebant, a treatment under investigation for Stargardt disease type 1 (STGD1). The study enrolled 60 adolescent subjects, including 15 participants from …
The defining characteristic of enduring wealth creation is ownership of businesses that sit at the irreversible chokepoints of global value chains. ASML Holding NV represents precisely such an enterprise. As the sole provider of extreme ultraviolet (EUV) lithography systems—and the uncontested leader in next-generation …
Please wait processing your request...